ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0262

Bartonella Endocarditis as an Important Mimic of ANCA Associated Vasculitis: Results of a Large Single Center Descriptive Analysis

Adam Brown1, Adil Vural2, Cassandra Calabrese3 and Leonard Calabrese2, 1Cleveland Clinic Foundation, Cleveland, OH, 2Cleveland Clinic, Cleveland, OH, 3Cleveland Clinic Foundation, Cleveland Heights, OH

Meeting: ACR Convergence 2024

Keywords: ANCA, Arthritis, Infectious, Infection

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 16, 2024

Title: Infection-related Rheumatic Disease Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Infective Endocarditis (IE) is an important mimic of numerous forms of systemic vasculitis and especially Anti-Neutrophilic Cytoplasmic Antibody vasculitis (AAV). Bartonella endocarditis (BE) is the leading culture negative endocarditis, leading to missed diagnosis even in patients screened with blood cultures. BE causes multiple clinical features that overlap with AAV including Glomerulonephritis (GN). ANCA positivity has been reported in upwards of 60-75% of cases of BE. BE associated renal pathologic descriptions are heterogeneous, most often revealing vary degrees of immune complex GN and more rarely pauci-immune GN. 

Critically if BE is missed and immunosuppression is given for presumed AAV, the outcomes can be fatal. The goal of the current study is to analyze all cases of BE associated GN at our institute and describe laboratory findings to potentially better recognize BE cases and reduce potentially fatal missed diagnosis.

Methods: A systemic search of our health systems EMR for hospitalized patients including with positive Bartonella Henselae Antibody titer IgG or “Bartonella Infection.”  Definitive diagnosis of Bartonella was made if valvular histology demonstrated either positive Warthin Starry staining or Bartonella PCR. Probable Bartonella diagnosis was made with high titer serum Bartonella IgG ( >1:256) or Bartonella PCR blood positivity in combination with abnormalities seen on echocardiogram. Besides the diagnosis of BE, patients also required evidence of GN. GN was considered definitive if consistent renal histopathology was available. GN was considered probable with new onset acute kidney injury and microscopic hematuria at the time of Bartonella diagnosis. Patients who fulfilled definitive or probable BE and definitive or probable GN were included in the cohort.   Multiple data points were collected including autoimmune serologies. Thrombocytopenia was defined as a platelet count of less than 150 k/uL, leukopenia defined as a white blood cell less than 3.70 k/uL at any point during their hospitalization.

Results: 20 patients with BE were included in this cohort. 80% had known underling cardiac valve disease (Table 1). During initial hospitalization, 90% of patients had thrombocytopenia, 60% leukopenia and ANCA was detected in 87% of cases when checked. Either C3 or C4 were low in 75% of cases. Only 25% of echocardiograms revealed vegetations (Table 2). Renal histology was considered Pauci-Immune in 50% of cases (Table 3).

Conclusion: BE is an important mimic of AAV.  Even when the diagnosis of endocarditis is being considered, Bartonella can be missed as it’s typically culture negative and only a minority of echocardiograms demonstrated vegetations. We present the largest single-center cohort of BE with GN. ANCA positivity was higher than in other cohorts at 87% as well our cohort had higher rates of (50%) of pauci-immune GN. The majority of echocardiograms did not reveal features considered specific for endocarditis such as vegetations.  Of note, 90% of cases had thrombocytopenia at presentation as well as the majority (75%) had low serum complements both atypical features for primary AAV and should prompt further investigation for secondary causes of ANCA positivity.  

Supporting image 1

Supporting image 2

RBC=Red blood cell, Concordance between Indirect Immunofluorescence Assay (IIF) and antigen occurs when C-ANCA and Proteinase_3 (PR3) antigen are together or P-ANCA and Myeloperoxidase(MPO) antigen are together.

Supporting image 3


Disclosures: A. Brown: Amgen, 1, 2, 6; A. Vural: None; C. Calabrese: AstraZeneca, 2, 6, sanofi, 2, 6; L. Calabrese: Amgen, 2, 6, AstraZeneca, 2, jansen, 2, sanofi, 2, UCB, 2, 6.

To cite this abstract in AMA style:

Brown A, Vural A, Calabrese C, Calabrese L. Bartonella Endocarditis as an Important Mimic of ANCA Associated Vasculitis: Results of a Large Single Center Descriptive Analysis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/bartonella-endocarditis-as-an-important-mimic-of-anca-associated-vasculitis-results-of-a-large-single-center-descriptive-analysis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bartonella-endocarditis-as-an-important-mimic-of-anca-associated-vasculitis-results-of-a-large-single-center-descriptive-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology